Literature DB >> 23306861

Association of left ventricular hypertrophy with high-sensitive C-reactive protein in hemodialysis patients.

Ali Monfared1, Arsalan Salari, Ehsan Kazemnezhad, Mohammadkazem Lebadi, Masoud Khosravi, Neda Kalantar Mehrjardi, Shahrzad Rahimifar, Nazly Amini.   

Abstract

BACKGROUND: Micro inflammation and cardiovascular disease such as left ventricular hypertrophy (LVH) are common in hemodialysis (HD) patients. Hence, we have evaluated the relationship between high-sensitive C-reactive protein (hs-CRP), as an inflammation marker, and left ventricular mass index (LVMi) and left ventricular mass (LVM) in HD patients.
METHODS: An analytical cross-sectional study was performed in 104 HD patients. Serum hs-CRP, LVMi, LVM, and blood pressure were evaluated; demographic data and duration of HD were also recorded. Finally, results were analyzed by using Student's t test, Pearson's correlation coefficient, one-way ANOVA and multiple regression to determine the relationship between LVMi and other variables.
RESULTS: A total of 66 male patients (63.46 %) and 38 female patients, with a mean age of 51.75 ± 15.98 years-old, participated in this study. Hypertension was the most common underlying disease (65.4 %). The mean LVMi was 366.98 ± 120.89 g/m(2) and the mean hs-CRP was 8.55 mg/l. Eighty-nine percent of patients had LVH. The hs-CRP level was significantly associated with age and with LVM (P = 0.0001, P = 0.039, respectively). On multivariate analysis, hs-CRP and systolic blood pressure were found to be independent predictors of LVM and LVMi.
CONCLUSIONS: This study shows that hs-CRP and systolic BP are independent predictors of LVH in HD patients.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23306861     DOI: 10.1007/s11255-012-0375-x

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  35 in total

Review 1.  Clinical application of C-reactive protein for cardiovascular disease detection and prevention.

Authors:  Paul M Ridker
Journal:  Circulation       Date:  2003-01-28       Impact factor: 29.690

Review 2.  Inflammation in renal disease.

Authors:  Donald G Vidt
Journal:  Am J Cardiol       Date:  2005-12-01       Impact factor: 2.778

Review 3.  Clinical epidemiology of cardiovascular disease in chronic renal disease.

Authors:  R N Foley; P S Parfrey; M J Sarnak
Journal:  Am J Kidney Dis       Date:  1998-11       Impact factor: 8.860

Review 4.  Left ventricular mass in chronic kidney disease and ESRD.

Authors:  Richard J Glassock; Roberto Pecoits-Filho; Silvio H Barberato
Journal:  Clin J Am Soc Nephrol       Date:  2009-12       Impact factor: 8.237

5.  Risk factors for the development of left ventricular hypertrophy in a prospectively followed cohort of dialysis patients.

Authors:  J D Harnett; G M Kent; P E Barre; R Taylor; P S Parfrey
Journal:  J Am Soc Nephrol       Date:  1994-01       Impact factor: 10.121

6.  Quantitative and qualitative alterations of acute-phase proteins in healthy elderly persons.

Authors:  S P Ballou; F B Lozanski; S Hodder; D L Rzewnicki; L C Mion; J D Sipe; A B Ford; I Kushner
Journal:  Age Ageing       Date:  1996-05       Impact factor: 10.668

7.  Outcome of congestive heart failure, dilated cardiomyopathy, hypertrophic hyperkinetic disease, and ischemic heart disease in dialysis patients.

Authors:  P S Parfrey; S M Griffiths; J D Harnett; R Taylor; A King; J Hand; P E Barre
Journal:  Am J Nephrol       Date:  1990       Impact factor: 3.754

8.  Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease.

Authors:  A S Levey; J A Beto; B E Coronado; G Eknoyan; R N Foley; B L Kasiske; M J Klag; L U Mailloux; C L Manske; K B Meyer; P S Parfrey; M A Pfeffer; N K Wenger; P W Wilson; J T Wright
Journal:  Am J Kidney Dis       Date:  1998-11       Impact factor: 8.860

9.  Comparison of C-reactive protein and high-sensitivity C-reactive protein levels in patients on hemodialysis.

Authors:  Imed Helal; Lilia Zerelli; Madiha Krid; Fethi ElYounsi; Hedi Ben Maiz; Bechir Zouari; Jaouida Adelmoula; Adel Kheder
Journal:  Saudi J Kidney Dis Transpl       Date:  2012-05

10.  The relation of C--reactive protein to chronic kidney disease in African Americans: the Jackson Heart Study.

Authors:  Ervin R Fox; Emelia J Benjamin; Daniel F Sarpong; Harsha Nagarajarao; Jason K Taylor; Michael W Steffes; Abdullah K Salahudeen; Michael F Flessner; Ermeg L Akylbekova; Caroline S Fox; Robert J Garrison; Herman A Taylor
Journal:  BMC Nephrol       Date:  2010-01-15       Impact factor: 2.388

View more
  10 in total

1.  Parathormone Levels Are Independently Associated with the Presence of Left Ventricular Hypertrophy in Patients with Coronary Artery Disease.

Authors:  Á Aceña; A M Pello; R Carda; Ó Lorenzo; M L Gonzalez-Casaus; L M Blanco-Colio; J L Martín-Ventura; J Palfy; M Orejas; R Rábago; E Gonzalez-Parra; I Mahíllo-Fernández; J Farré; J Egido; J Tuñón
Journal:  J Nutr Health Aging       Date:  2016       Impact factor: 4.075

Review 2.  Does inflammation affect outcomes in dialysis patients?

Authors:  Kristen L Nowak; Michel Chonchol
Journal:  Semin Dial       Date:  2018-03-07       Impact factor: 3.455

3.  The impact of sub-clinical over-hydration on left ventricular mass in peritoneal dialysis patients.

Authors:  Kamal Hassan; Dunia Hassan; Alexander Shturman; Irina Rubinchik; Hassan Fadi; Hassan Shadi; Shaul Atar
Journal:  Int J Clin Exp Med       Date:  2015-04-15

4.  Antemortem Screening for Left Ventricular Hypertrophy in Rhesus Macaques (Macaca mulatta).

Authors:  Andrew J Haertel; Joshua A Stern; J Rachel Reader; Abigail Spinner; Jeffrey A Roberts; Kari L Christe
Journal:  Comp Med       Date:  2016       Impact factor: 0.982

5.  Does low peritoneal glucose load protect from the development of left ventricular hypertrophy in peritoneal dialysis patients?

Authors:  Kamal Hassan; Fadi Hassan; Dunia Hassan; Saab Anwar; Hassan Shadi
Journal:  Clin Exp Nephrol       Date:  2015-11-22       Impact factor: 2.801

6.  Serum osteopontin, but not OPN gene polymorphism, is associated with LVH in essential hypertensive patients.

Authors:  Xuwei Hou; Zhaohui Hu; Xiaohua Huang; Yan Chen; Xiuying He; Haiying Xu; Ningfu Wang
Journal:  J Mol Med (Berl)       Date:  2013-12-27       Impact factor: 4.599

7.  The association between BMP4 gene polymorphism and its serum level with the incidence of LVH in hypertensive patients.

Authors:  G L Gu; Q Y Yang; R L Zeng; X L Xu
Journal:  J Transl Med       Date:  2015-01-16       Impact factor: 5.531

8.  Association between Inflammation and Cardiac Geometry in Chronic Kidney Disease: Findings from the CRIC Study.

Authors:  Jayanta Gupta; Elizabeth A Dominic; Jeffrey C Fink; Akinlolu O Ojo; Ian R Barrows; Muredach P Reilly; Raymond R Townsend; Marshall M Joffe; Sylvia E Rosas; Melanie Wolman; Samir S Patel; Martin G Keane; Harold I Feldman; John W Kusek; Dominic S Raj
Journal:  PLoS One       Date:  2015-04-24       Impact factor: 3.240

9.  The impact of oxidized serum albumin on the oncotic pressure and hydration status of peritoneal dialysis patients.

Authors:  Kamal Hassan; Batya Kristal; Fadi Hassan; Saad Abo Saleh; Regina Michelis
Journal:  Ther Clin Risk Manag       Date:  2016-03-24       Impact factor: 2.423

10.  The relationship between hydration status, male sexual dysfunction and depression in hemodialysis patients.

Authors:  Kamal Hassan; Yotam Elimeleh; Mona Shehadeh; Hassan Fadi; Irina Rubinchik
Journal:  Ther Clin Risk Manag       Date:  2018-03-13       Impact factor: 2.423

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.